Episodic Ataxia Type 2

Neurotherapeutics

Volumn 4, Issue 2, 2007, Pages 267-273

  Strupp, Michael ^a   Zwergal, Andreas ^a   Brandt, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

acetazolamide; aminopyridine; downbeat nystagmus; Episodic ataxia type 2; PQ calcium channel

Indexed keywords

4 AMINOPYRIDINE; ACETAZOLAMIDE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; SULTIAME; VALPROIC ACID; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; ATAXIA; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ATROPHY; CACNA1A GENE; CALCIUM CHANNELOPATHY; CEREBELLUM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE MODEL; EPISODIC ATAXIA TYPE 2; FATIGUE; GASTROINTESTINAL SYMPTOM; GENE; HUMAN; HYPERHIDROSIS; MISSENSE MUTATION; MUSCLE STIFFNESS; NEPHROLITHIASIS; NONHUMAN; NYSTAGMUS; OPHTHALMOPLEGIA; PARESTHESIA; PRIORITY JOURNAL; SYMPTOM; VERTIGO;

4-AMINOPYRIDINE; ACETAZOLAMIDE; ANIMALS; CALCIUM CHANNELS; CARBONIC ANHYDRASE INHIBITORS; CEREBELLAR ATAXIA; DISEASE MODELS, ANIMAL; HUMANS; MUTATION; POTASSIUM CHANNEL BLOCKERS;

EID: 33947546576     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.01.014     Document Type: Article

References (68)

1. Browne D.L., Gancher S.T., Nutt J.G., et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8 (1994) 136-140
2. Maylie B., Bissonnette E., Virk M., Adelman J.P., and Maylie J.G. Episodic ataxia type 1 mutations in the human Kv1.1 potassium channel alter hKvβ1-induced N-type inactivation. J Neurosci 22 (2002) 4786-4793
3. Vaamonde J., Artieda J., and Obeso J.A. Hereditary paroxysmal ataxia with neuromyotonia. Mov Disord 6 (1991) 180-182
4. Steckley J.L., Ebers G.C., Cader M.Z., and McLachlan R.S. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 57 (2001) 1499-1502
5. Farmer T.W., and Mustian V.M. Vestibulocerebellar ataxia: a newly defined hereditary syndrome with periodic manifestations. Arch Neurol 8 (1963) 471-480
6. Escayg A., De Waard M., Lee D.D., et al. Coding and noncoding variation of the human calcium-channel β4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 66 (2000) 1531-1539
7. Jen J.C., Wan J., Palos T.P., Howard B.D., and Baloh R.W. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65 (2005) 529-534
8. Auburger G., Ratzlaff T., Lunkes A., et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 31 (1996) 90-94
9. Griggs R.C., and Nutt J.G. Episodic ataxias as channelopathies. Ann Neurol 37 (1995) 285-287
10. Ophoff R.A., Terwindt G.M., Vergouwe M.N., et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87 (1996) 543-552
11. Brandt T., and Strupp M. Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo). Audiol Neurootol 2 (1997) 373-383
12. Imbrici P., Eunson L.H., Graves T.D., et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65 (2005) 944-946
13. Gancher S.T., and Nutt J.G. Autosomal dominant episodic ataxia: a heterogeneous syndrome. Mov Disord 1 (1986) 239-253
14. Jen J., Kim G.W., and Baloh R.W. Clinical spectrum of episodic ataxia type 2. Neurology 62 (2004) 17-22
15. Brandt T., and Strupp M. Migraine and vertigo: Classification, clinical features and special treatment considerations. Headache Currents 3 (2006) 12-19
16. Oh A.K., Lee H., Jen J.C., Corona S., Jacobson K.M., and Baloh R.W. Familial benign recurrent vertigo. Am J Med Genet 100 (2001) 287-291
17. Lempert T., and Neuhauser H. Migrainous vertigo. Neurol Clin 23 (2005) 715-730 vi
18. Sasaki O., Jen J.C., Baloh R.W., Kim G.W., Isawa M., and Usami S. Neurotological findings in a family with episodic ataxia. J Neurol 250 (2003) 373-375
19. Rucker J.C., Jen J., Stahl J.S., Natesan N., Baloh R.W., and Leigh R.J. Internuclear ophthalmoparesis in episodic ataxia type 2. Ann N Y Acad Sci 1039 (2005) 571-574
20. Mochizuki Y., Kawata A., Mizutani T., et al. Hereditary paroxysmal ataxia with mental retardation: a clinicopathological study in relation to episodic ataxia type 2. Acta Neuropathol (Berl) 108 (2004) 345-349
21. Spacey S.D., Materek L.A., Szczygielski B.I., and Bird T.D. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 62 (2005) 314-316
22. Van Bogaert P., and Szliwowski H.B. EEG findings in acetazolamide-responsive hereditary paroxysmal ataxia. Neurophysiol Clin 26 (1996) 335-340
23. Imbrici P., Jaffe S.L., Eunson L.H., et al. Dysfunction of the brain calcium channel Cav2.1 in absence epilepsy and episodic ataxia. Brain 127 (2004) 2682-2692
24. Vighetto A., Froment J.C., Trillet M., and Aimard G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol 45 (1988) 547-549
25. Hawkes C.H. Familial paroxysmal ataxia: report of a family. J Neurol Neurosurg Psychiatry 55 (1992) 212-213
26. Bain P.G., O'Brien M.D., Keevil S.F., and Porter D.A. Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31 (1992) 147-154
27. Harno H., Heikkinen S., Kaunisto M.A., et al. Decreased cerebellar total creatine in episodic ataxia type 2: a 1H MRS study. Neurology 64 (2005) 542-544
28. Vahedi K., Joutel A., Van Bogaert P., et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 37 (1995) 289-293
29. von Brederlow B., Hahn A.F., Koopman W.J., Ebers G.C., and Bulman D.E. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 4 (1995) 279-284
30. + channel activity in sympathetic neurons. Life Sci 68 (2001) 2481-2487
31. Eunson L.H., Graves T.D., and Hanna M.G. New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology 65 (2005) 308-310
32. Wan J., Khanna R., Sandusky M., Papazian D.M., Jen J.C., and Baloh R.W. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology 64 (2005) 2090-2097
33. Guida S., Trettel F., Pagnutti S., et al. Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 68 (2001) 759-764
34. 2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 277 (2002) 6960-6966
35. Jodice C., Mantuano E., Veneziano L., et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 6 (1997) 1973-1978
36. 2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci USA 99 (2002) 13284-13289
37. Zhuchenko O., Bailey J., Bonnen P., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel. Nat Genet 15 (1997) 62-69
38. Maselli R.A., Wan J., Dunne V., et al. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 61 (2003) 1743-1748
39. Walter J.T., Alvina K., Womack M.D., Chevez C., and Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 9 (2006) 389-397
40. Strupp M., Kalla R., Dichgans M., Freilinger T., Glasauer S., and Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62 (2004) 1623-1625
41. Hirose H., Arayama T., Takita J., Igarashi T., Hayashi Y., and Nagao Y. A family of episodic ataxia type 2: no evidence of genetic linkage to the CACNA1A gene. Int J Mol Med 11 (2003) 187-189
42. Cader M.Z., Steckley J.L., Dyment D.A., McLachlan R.S., and Ebers G.C. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 65 (2005) 156-158
43. + channel function. FASEB J 13 (1999) 1335-1345
44. Sappey-Marinier D., Vighetto A., Peyron R., Broussolle E., and Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol 46 (1999) 256-259
45. Fletcher C.F., Lutz C.M., O'Sullivan T.N., et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87 (1996) 607-617
46. Fureman B.E., and Hess E.J. Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathy. Neurobiol Dis 20 (2005) 227-232
47. Weisz C.J., Raike R.S., Soria-Jasso L.E., and Hess E.J. Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci 25 (2005) 4141-4145
48. Lorenzon N.M., Lutz C.M., Frankel W.N., and Beam K.G. Altered calcium channel currents in Purkinje cells of the neurological mutant mouse leaner. J Neurosci 18 (1998) 4482-4489
49. rol). J Neurosci 20 (2000) 5654-5662
50. Calandriello L., Veneziano L., Francia A., et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain 120 (1997) 805-812
51. Griggs R.C., Moxley III R.T., Lafrance R.A., and McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28 (1978) 1259-1264
52. Harno H., Hirvonen T., Kaunisto M.A., et al. Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2). J Neurol 251 (2004) 232-234
53. Griggs R.C., Engel W.K., and Resnick J.S. Acetazolamide treatment of hypokalemic periodic paralysis: prevention of attacks and improvement of persistent weakness. Ann Intern Med 73 (1970) 39-48
54. Vroom F.W., Jarrell M.A., and Maren T.H. Acetazolamide treatment of hypokalemic periodic paralysis: probable mechanism of action. Arch Neurol 32 (1975) 385-392
55. Johnsen T. Effect upon serum insulin, glucose and potassium concentrations of acetazolamide during attacks of familial periodic hypokalemic paralysis. Acta Neurol Scand 56 (1977) 533-541
56. Goulon M., Raphael J.C., and Simon N. Periodic familial paralysis with hypokalemia: hemodynamic and metabolic studies: favorable effect of acetazolamide. [In French]. Rev Neurol (Paris) 134 (1978) 655-672
57. Donat J.R., and Auger R. Familial periodic ataxia. Arch Neurol 36 (1979) 568-569
58. Zasorin N.L., Baloh R.W., and Myers L.B. Acetazolamide-responsive episodic ataxia syndrome. Neurology 33 (1983) 1212-1214
59. + channel mutations causing hypokalaemic periodic paralysis type II. Brain 125 (2002) 835-843
60. Woodhull A.M. Ionic blockage of sodium channels in nerve. J Gen Physiol 61 (1973) 687-708
61. Spacey S.D., Hildebrand M.E., Materek L.A., Bird T.D., and Snutch T.P. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol 56 (2004) 213-220
62. Brunt E.R., and van Weerden T.W. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 113 (1990) 1361-1382
63. Scoggan K.A., Friedman J.H., and Bulman D.E. CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid. Can J Neurol Sci 33 (2006) 68-72
64. Strupp M., Schuler O., Krafczyk S., et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61 (2003) 165-170
65. Etzion Y., and Grossman Y. Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139 (2001) 419-425
66. Kullmann D.M., and Hanna M.G. Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol 1 (2002) 157-166
67. Kordasiewicz H.B., and Gomez C.M. Molecular pathogenesis of spinocerbellar ataxia type 6. Neurotherapeutics 4 (2007) 285-294
68. Rajakulendran S., Schorge S., Kullmann D.M., and Hanna M.G. Episodic ataxia type 1: A neuronal potassium channelopathy. Neurotherapeutics 4 (2007) 258-266